Skip to main content

Find Clinical Trials

Home
Conditions
Neuromuscular Junction Diseases

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

296 public trials 100 recruiting studies

Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Completed

Biomarkers in Neural Disorders

NCT02761707

Conditions: Alzheimer Disease, Alzheimer's Disease, Autoimmune Diseases, +45 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Incidence and Risk of Influenza in Myasthenic Patients

NCT03884777

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

NCT02473952

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States

University of California-Irvine Orange, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

University of Florida Health Science Center Jacksonville, Florida, United States

View all 40 locations

View Trial Details

Completed

Transsternal Versus Transcervical Thymectomy

NCT03825185

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis

NCT02609022

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: University Hospital, Antwerp Edegem, Antwerp, Belgium

View Trial Details

Completed

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

NCT02970162

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: UCLA Los Angeles, California, United States

View Trial Details

Completed

Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632

NCT02779140

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Botulism, +10 more
Locations: Duke Human Vaccine Institute - Duke Clinical Vaccine Unit Durham, North Carolina, United States

View Trial Details

Completed

Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis

NCT02066519

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +12 more
Locations: ICU and medical surgery department, Raymond Poincaré Hospital Garches, Hauts-de-Seine, France

View Trial Details

Completed

A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

NCT01377922

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +12 more
Locations: Birmingham, Alabama, United States

Scottsdale, Arizona, United States

Los Angeles, California, United States

Palo Alto, California, United States

View all 14 locations

View Trial Details

Completed

Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

NCT00987116

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Hopital Raymond Poincaré Garches, France

View Trial Details